Patents by Inventor Hai-Rong Li
Hai-Rong Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11965156Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: GrantFiled: December 7, 2021Date of Patent: April 23, 2024Assignee: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li
-
Publication number: 20220090049Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: ApplicationFiled: December 7, 2021Publication date: March 24, 2022Applicant: Quest Diagnostics Investments LLCInventors: Heather SANDERS, Hai-Rong Li
-
Publication number: 20220033901Abstract: Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.Type: ApplicationFiled: August 9, 2021Publication date: February 3, 2022Applicant: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li, Feras Hantash, Frederic Waldman
-
Patent number: 11193120Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: GrantFiled: November 22, 2019Date of Patent: December 7, 2021Assignee: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li
-
Patent number: 11085079Abstract: Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.Type: GrantFiled: October 26, 2018Date of Patent: August 10, 2021Assignee: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li, Feras Hantash, Frederic Waldman
-
Publication number: 20200157527Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: ApplicationFiled: November 22, 2019Publication date: May 21, 2020Applicant: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li
-
Patent number: 10494629Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: GrantFiled: August 31, 2018Date of Patent: December 3, 2019Assignee: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li
-
Publication number: 20190112657Abstract: Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.Type: ApplicationFiled: October 26, 2018Publication date: April 18, 2019Applicant: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li, Feras Hantash, Frederic Waldman
-
Publication number: 20190062726Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: ApplicationFiled: August 31, 2018Publication date: February 28, 2019Applicant: Quest Diagnostics Investments LLCInventors: Heather Sanders, Hai-Rong Li
-
Patent number: 10138519Abstract: Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.Type: GrantFiled: December 27, 2013Date of Patent: November 27, 2018Assignee: Quest Diagnostics Investments IncorporatedInventors: Heather Sanders, Hai-Rong Li, Feras Hantash, Frederic Waldman
-
Patent number: 10066226Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: GrantFiled: April 15, 2016Date of Patent: September 4, 2018Assignee: Quest Diagnostics Investments IncorporatedInventors: Heather Sanders, Hai-Rong Li
-
Publication number: 20170073669Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: ApplicationFiled: April 15, 2016Publication date: March 16, 2017Applicant: QUEST DIAGNOSTICS INVESTMENTS INCORPORATEDInventors: HEATHER SANDERS, HAI-RONG LI
-
Patent number: 9315802Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: GrantFiled: December 20, 2010Date of Patent: April 19, 2016Assignee: QUEST DIAGNOSTICS INVESTMENTS INCORPORATEDInventors: Heather Sanders, Hai-Rong Li
-
Publication number: 20150344948Abstract: Described herein are methods, compositions and kits directed to amplification of nucleic acids suitable for both next generation sequencing (NGS) and a second round of sequencing as validation, such as Sanger sequencing.Type: ApplicationFiled: December 27, 2013Publication date: December 3, 2015Applicant: Quest Diagnostics Investment IncorporatedInventors: Heather SANDERS, Hai-Rong LI, Feras HANTASH, Frederic WALDMAN
-
Publication number: 20110159550Abstract: The invention provides methods for isolating RNA from the soluble fraction of urine. The methods can be used for detecting the presence or absence of an RNA, or quantifying the amount of an RNA. The methods are useful for diagnosing an individual suspected of having a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine. The methods are also useful for prognosing an individual diagnosed with a disease by detecting the level of RNA associated with the disease in the soluble fraction of urine.Type: ApplicationFiled: December 20, 2010Publication date: June 30, 2011Inventors: Heather Sanders, Hai-Rong Li
